Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Surface Oncology, Inc.    SURF

SURFACE ONCOLOGY, INC.

(SURF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about SURFACE ONCOLOGY, INC.
11/25SURFACE ONCOLOGY : to Participate in the 3rd Annual Evercore ISI HealthCONx Conf..
AQ
11/25Surface Oncology to Participate in the 3rd Annual Evercore ISI HealthCONx Con..
GL
11/13SURFACE ONCOLOGY : Announces SRF617 and SRF388 Will Advance to Combination and E..
AQ
11/13Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and ..
GL
11/11SURFACE ONCOLOGY : Announces FDA Fast Track Designation Granted by U.S. Food and..
AQ
11/11Surface Oncology Announces FDA Fast Track Designation Granted by U.S. Food an..
GL
11/10SURFACE ONCOLOGY : Reports Financial Results and Corporate Highlights for Third ..
AQ
11/10Surface Oncology Reports Financial Results and Corporate Highlights for Third..
GL
11/09SURFACE ONCOLOGY : to Present at the Cowen IO Next Summit
AQ
11/09Surface Oncology to Present at the Cowen IO Next Summit
GL
11/09SURFACE ONCOLOGY : to Present SRF388 and SRF114 Preclinical Data at the Upcoming..
AQ
11/09Surface Oncology to Present SRF388 and SRF114 Preclinical Data at the Upcomin..
GL
10/26SURFACE ONCOLOGY : to Report SRF388 Preclinical Data at the Upcoming Internation..
AQ
10/26Surface Oncology to Report SRF388 Preclinical Data at the Upcoming Internatio..
GL
09/16SURFACE ONCOLOGY : to Participate in the Oppenheimer Fall Healthcare Life Scienc..
AQ
09/16Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Scien..
GL
09/11SURFACE ONCOLOGY : to Participate in the H.C. Wainwright Global Healthcare Confe..
AQ
09/11Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conf..
GL
09/09SURFACE ONCOLOGY : to Present at the Baird Global Healthcare Conference
AQ
09/09Surface Oncology to Present at the Baird Global Healthcare Conference
GL
08/11Surface Oncology Reports Financial Results and Corporate Highlights for Secon..
GL
08/05SURFACE ONCOLOGY : to Present at the 2020 Wedbush PacGrow Healthcare Virtual Con..
AQ
05/28Surface Oncology Announces Change to Location and Format of 2020 Annual Meeti..
GL
05/21SURFACE ONCOLOGY : Continues Gains, Up 45%; In Clinical Trial Collaboration with..
DJ
05/20Surface Oncology Shares Rise on Merck Collaboration
DJ
05/20Surface Oncology, Merck to Study SRF617, Keytruda Combination
DJ
05/20Surface Oncology Fully Utilizes its $30M At-the-Market Facility
GL
05/20Surface Oncology and Merck to Collaborate on Immuno-Oncology Study Evaluating..
GL
05/15SURFACE ONCOLOGY : to Present Preclinical Data for Multiple Product Programs at ..
AQ
05/14Surface Oncology to Present at the American Society of Clinical Oncology Annu..
GL
05/13Surface Oncology to Present at the UBS Virtual Global Healthcare Conference
GL
05/12SURFACE ONCOLOGY : Reports Financial Results and Corporate Highlights for First ..
AQ
04/23Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-On..
GL
03/17Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-On..
GL
03/10SURFACE ONCOLOGY : Securities offered to employees pursuant to employee benefit ..
PU
03/10Surface Oncology Reports Financial Results and Corporate Highlights for Fourt..
GL
02/25Surface Oncology to Present at the 40th Annual Cowen Healthcare Conference
GL
01/27Surface Oncology Announces FDA Clearance of SRF617 and SRF388 INDs to Initiat..
GL
2019NOTICE TO SHAREHOLDERS OF SURFACE ON : SURF) Regarding Dismissal of Putative Inv..
BU
2019Surface Oncology to Present at Evercore ISI 2nd Annual HealthCONx Conference
GL
2019Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures
GL
2019Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate..
GL
2019Surface Oncology Reports Financial Results and Corporate Highlights for Third..
GL
2019Surface Oncology Presents Updates at the Society for Immunotherapy of Cancer'..
GL
2019Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New..
GL
2019Surface Oncology to Present at the Baird 2019 Global Healthcare Conference
GL
2019Ramy Ibrahim, M.D. to Join Surface Oncology Board of Directors
GL
2019Surface Oncology Reports Financial Results and Corporate Highlights for Secon..
GL
2019SHAREHOLDER ALERT : Robbins Arroyo LLP is Investigating Surface Oncology, Inc. (..
BU
2019INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claim..
BU
2019SURFACE ONCOLOGY : Shareholder Rights Law Firm Johnson Fistel Launches Investiga..
PR
2019INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims A..
BU
2019Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcar..
GL
2019Surface Oncology Management to Present at the Solebury Trout Class of 2018 Bi..
GL
2019Surface Oncology Reports Financial Results and Corporate Highlights for Fourt..
GL
2019Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference
GL
2019Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Tar..
GL
2018Surface Oncology Added to the NASDAQ Biotechnology Index
GL
2018Surface Oncology Resets Portfolio Priorities, Extends Cash Runway Through 202..
GL
2018Surface Oncology Promotes Jessica Fees to Senior Vice President, Finance and ..
GL
2018Surface Oncology Announces Upcoming Investor Presentations
GL
2018Surface Oncology to Present at the Baird 2018 Global Healthcare Conference
GL
2018Surface Oncology Reports Financial Results and Corporate Highlights for Secon..
GL
2018Surface Oncology Recognized as one of the “Best Places to Work” b..
GL
2018Surface Oncology to be Added to the Russell 3000 Index and Russell 2000 Index
GL
2018Surface Oncology to Present at 2018 UBS Global Healthcare Conference
GL
2018Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Con..
GL
Upcoming event on SURFACE ONCOLOGY, INC.